Zhang, Emily http://orcid.org/0000-0002-9053-1336
Neugebauer, Monica E.
Krasnow, Nicholas A.
Liu, David R. http://orcid.org/0000-0002-9943-7557
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM118062)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01AI142756)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB027793, R01EB031172)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL156647)
Howard Hughes Medical Institute (Liu investigatorship)
Article History
Received: 24 October 2023
Accepted: 7 February 2024
First Online: 24 February 2024
Competing interests
: The authors declare competing financial interests: The Broad Institute has filed a patent application on behalf of E.Z., M.E.N., and D.R.L on the base editors developed in this study. D.R.L. is a consultant for Prime Medicine, Beam Therapeutics, Pairwise Plants, Chroma Medicine, and Nvelop Therapeutics, companies that use or deliver agents for genome editing, epigenome engineering, or PACE, and owns equity in these companies. The remaining authors declare no competing interests.